Oromandibular dystonia unresponsive to botulinum toxin: two illustrative cases of condylar dislocation as a structural mimic - Scorecard - DentalSpire

Oromandibular Dystonia Resistant to Botulinum Toxin: Two Case Studies Highlighting Condylar Dislocation as a Structural Mimicker

  • By

  • Olcay Şakar

  • Berk Bilgen

  • Bora Edim Akalın

  • Kazuya Yoshida

  • July 20, 2026

Share

Clinical Scorecard: Oromandibular Dystonia Resistant to Botulinum Toxin: Two Case Studies Highlighting Condylar Dislocation as a Structural Mimicker

At a Glance

CategoryDetail
ConditionOromandibular Dystonia (OMD)
Key MechanismsInvolves abnormal muscle contractions affecting masticatory and facial muscles; can be mimicked by structural disorders like condylar dislocation.
Target PopulationPatients with suspected OMD and non-responsive to botulinum toxin therapy.
Care SettingNeurology and oral/maxillofacial evaluation.

Key Highlights

  • Botulinum toxin is a standard treatment for OMD but may not be effective in all cases.
  • Long-standing condylar dislocation can mimic OMD symptoms.
  • Non-response to botulinum toxin should trigger reassessment of diagnosis.
  • Structural evaluation is crucial in cases of fixed mandibular deviation.
  • Both cases improved after structural correction and prosthetic rehabilitation.

Guideline-Based Recommendations

Diagnosis

  • Consider structural disorders in patients with OMD-like symptoms and non-response to treatment.
  • Use dental imaging and oral/maxillofacial consultation for accurate diagnosis.

Management

  • Botulinum toxin injections should be reconsidered if there is no meaningful benefit.
  • Structural correction may be necessary for conditions like long-standing condylar dislocation.

Monitoring & Follow-up

  • Monitor for signs of structural disorders in patients with OMD symptoms.

Risks

  • Misdiagnosis of structural disorders as OMD may lead to ineffective treatment.

Patient & Prescribing Data

Patients with oromandibular dystonia symptoms.

Botulinum toxin therapy may not address underlying structural issues.

Clinical Best Practices

  • Reassess diagnosis in patients with OMD who do not respond to botulinum toxin.
  • Incorporate dental imaging in the evaluation of suspected OMD cases.

Related Resources & Content

Original Source(s)

Related Content